Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hello folks, first time checking in on over 4 mos.. can't say how nice it is being out of this clown show... One of the best decisions I ever made to exit 95% of this position. Is Nader still around? Let me know when he's gone, I might increase position again.
DINGDINGDINGDING...we have a bingo
Another legitimate professional who has quickly entered and exited this company... That's all you need to know about NP... Ask 3x, he knows Anthony C... I also know Anthony C believes the drug has potential but NP is a toxin. This is getting ridiculous.
He should be put in jail. IMO.
Too long, no one is reading that
Point is, nader should be in freakin jail.
Has anyone actually verified anything he has ever said? I'm feeling more and more that it's just nonsense.
Share your model publicly if you're so confident. I personally would like to see it. I'm no statistician but am an actuary.. at a minimum I can make numbers talk, basically the same thing, right? :)
Haha uhh ok? No.
Well you left out the fact that you must have thought cd12 would fail... Even if you dislike management, an approval is going to provide a share price pop. Makes no sense to sell.
Similar story with MNKD some years back. I held through FDA approval of their insulin inhaler for diabetics... Small pop and eventually become a disaster of a company. FDA approval didn't guarantee a meteoric rise (they also had better mgmt vs cydy in my opinion).
Most definitely! We're probably looking at $20ish any day now. It will quickly move up from there once MORE people see all the other trials/indications that will quickly become approved.
Right... The study and trial were designed prior to this revision, so I would hope we are not held to this new standard... Maybe I shouldn't say that because lero probably works in new criteria anyway!
Just to be clear, most of the leg work is already done on the analysis. The hardest part is getting the data from hospitals and making sure it is clean, reliable, usable... This has been completed. The analysis shouldn't need more than a week if results are as good as we hope.
Question -
Without analysis, data is just data. How could unblinding of raw data be considered a material event? Wouldn't we need to wait for analysis on that data to even begin considering if it is good or bad?
You're supposed to do this type of modeling by using a 'reasonable' range (a distribution) for the unknown variables... I.e. in this case death rates. If you use garbage inputs the output, as you may have guessed, is garbage.
What you're describing sounds like monte carlo simulation which is dependant on YOUR dist inputs which I'm sure we're incorrect if these are the results you've landed on... Please do share some more detail
Article doesn't mention leronlimab or ccr5
Brilliant!
Examples please
Same same! Gimmeum CHEAP shares kid
Short interest is much higher than that. My PE buddy told me so ??
I'd imagine the NASDAQ has the option to not approve a listing on a case by case basis,example being a company without any revenue or approved product lol
Thank you for the clarification! Because of Nader's poor communication, nuances like this are often lost on people. I was really hoping it was something to do with your explanation and not another time line miss.
Like I said... Results are good... Hold shares and pick up what you can...it's apparent more people are now 'in the know'!
All of the above!!
I have it on good authority that peek preview on results is VERY favorable and to 'make sure you're holding your shares' and 'buying what you can'
With the amount of hubris np has, I would not be surprised if he's turned down some pretty good idea already.
People are starting to recognize the potential treatments that are not being utilised, ie monoclonal ie leronlimab
https://www.vox.com/22219434/covid-19-drugs-treatment-monoclonal-antibodies-plasma-antiviral-regeneron-remdesivir
You, or someone else, made the prediction... The short thesis will leverage and obfuscate these analysis release dates. It's what they're doing right now at this exact moment in coordination with the naked shorting.
Beautiful... It is easier to comprehend this happening when you realize that there a handful of people making these decisions within a corporation, and not necessarily the c-suite... Just people who need to hit a bottom line. Flawed, imperfect people.
Every person on this board has done research and modeling
What have you been doing exactly? What is your expertise?
Most important thing will be having an air tight story around the numbers. Can't leave any cracks for the likes of scum bag Fartstain to work in a spin.
Lol! Well said.
Lol... I'll 'pass this along' to my colleagues.
Poor guy.. I'll probably wait until it's at least $20 to start thinking about selling
clown show
do you know any other unapproved drugs that have their own code?
i wont hold my breath while waiting for your answer.
Bingo!! there you go! thank you very much :)